Size matters in atrial fibrillation: the underestimated importance of reduction of contiguous electrical mass underlying the effectiveness of catheter ablation.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
08 11 2021
Historique:
received: 10 11 2020
accepted: 22 03 2021
pubmed: 6 5 2021
medline: 1 4 2022
entrez: 5 5 2021
Statut: ppublish

Résumé

Evidence has accumulated over the last century of the importance of a critical electrical mass in sustaining atrial fibrillation (AF). AF ablation certainly reduces electrically contiguous atrial mass, but this is not widely accepted to be an important part of its mechanism of action. In this article, we review data showing that atrial size is correlated in many settings with AF propensity. Larger mammals are more likely to exhibit AF. This is seen both in the natural world and in animal models, where it is much easier to create a goat model than a mouse model of AF, for example. This also extends to humans-athletes, taller people, and obese individuals all have large atria and are more likely to exhibit AF. Within an individual, risk factors such as hypertension, valvular disease and ischaemia can enlarge the atrium and increase the risk of AF. With respect to AF ablation, we explore how variations in ablation strategy and the relative effectiveness of these strategies may suggest that a reduction in electrical atrial mass is an important mechanism of action. We counter this with examples in which there is no doubt that mass reduction is less important than competing theories such as ganglionated plexus ablation. We conclude that, when considering future strategies for the ablative therapy of AF, it is important not to discount the possibility that contiguous electrical mass reduction is the most important mechanism despite the disappointing consequence being that enhancing success rates in AF ablation may involve greater tissue destruction.

Identifiants

pubmed: 33948648
pii: 6264888
doi: 10.1093/europace/euab078
pmc: PMC8576280
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1698-1707

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/16/3/32175
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 220572/Z/20/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Europace. 2016 Dec;18(12):1758-1772
pubmed: 27247007
Circ Res. 2000 Dec 8;87(12):1103-7
pubmed: 11110766
Chest. 2004 Jun;125(6):2129-34
pubmed: 15189932
Eur Heart J. 2008 Jan;29(1):71-8
pubmed: 18065754
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1168-76, 1178.e1-2
pubmed: 26432719
J Cardiovasc Electrophysiol. 2007 Mar;18(3):269-75
pubmed: 17318996
J Cardiovasc Electrophysiol. 2018 May;29(5):687-695
pubmed: 29377478
Interact Cardiovasc Thorac Surg. 2011 Sep;13(3):332-8
pubmed: 21632865
Eur Heart J. 2009 May;30(9):1113-20
pubmed: 19304990
Eur Heart J. 2013 Dec;34(47):3624-31
pubmed: 23756332
Circulation. 2002 Nov 5;106(19):2479-85
pubmed: 12417546
Mayo Clin Proc. 2001 May;76(5):467-75
pubmed: 11357793
J Cardiovasc Electrophysiol. 2018 Nov;29(11):1471-1479
pubmed: 30230101
Heart Rhythm. 2015 Feb;12(2):283-90
pubmed: 25460865
JACC Clin Electrophysiol. 2019 Aug;5(8):968-976
pubmed: 31439299
Eur J Cardiovasc Prev Rehabil. 2010 Feb;17(1):100-5
pubmed: 20065854
Am J Cardiol. 1996 Jan 1;77(1):96-8
pubmed: 8540469
J Am Coll Cardiol. 2006 Feb 7;47(3):644-53
pubmed: 16458150
Circulation. 2000 Sep 19;102(12):1454-60
pubmed: 10993867
J Am Coll Cardiol. 1992 Jun;19(7):1531-5
pubmed: 1593049
Cardiovasc Res. 1999 Sep;43(4):947-57
pubmed: 10615422
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):
pubmed: 26962094
Europace. 2019 Aug 1;21(8):1176-1184
pubmed: 31071213
J Mol Cell Cardiol. 2000 Mar;32(3):355-64
pubmed: 10731435
Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H255-63
pubmed: 16113075
Circulation. 2002 Jan 15;105(2):251-7
pubmed: 11790709
J Am Heart Assoc. 2017 Sep 17;6(9):
pubmed: 28919580
Int J Cardiol. 1982;2(2):179-97
pubmed: 6185445
Auton Neurosci. 2020 Nov;228:102699
pubmed: 32769021
Europace. 2008 May;10(5):618-23
pubmed: 18390875
J Cardiovasc Electrophysiol. 2011 Oct;22(10):1171-3
pubmed: 21539640
Circulation. 2001 Nov 20;104(21):2539-44
pubmed: 11714647
J Cardiovasc Med (Hagerstown). 2011 Mar;12(3):162-6
pubmed: 21157365
J Am Coll Cardiol. 2017 Mar 14;69(10):1247-1256
pubmed: 28279291
Science. 1994 Nov 11;266(5187):1003-6
pubmed: 7973648
Arch Intern Med. 2006 Nov 27;166(21):2322-8
pubmed: 17130384
N Engl J Med. 2015 May 7;372(19):1812-22
pubmed: 25946280
Circ Arrhythm Electrophysiol. 2016 Jan;9(1):e003337
pubmed: 26763226
Circulation. 1997 Nov 4;96(9):3157-63
pubmed: 9386188
Cardiovasc Res. 1999 May;42(2):470-6
pubmed: 10533582
Circulation. 2000 Mar 28;101(12):1409-17
pubmed: 10736285
Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1229-35
pubmed: 24036225
J Am Coll Cardiol. 2012 Aug 14;60(7):628-36
pubmed: 22818076
Am J Cardiol. 1987 Sep 1;60(7):572-5
pubmed: 3630939
J Am Coll Cardiol. 2008 Jun 3;51(22):2153-60
pubmed: 18510963
Europace. 2011 Mar;13(3):355-61
pubmed: 21148171
J Am Coll Cardiol. 1994 Jun;23(7):1535-40
pubmed: 8195510
Cardiovasc Res. 2000 Nov;48(2):265-73
pubmed: 11054473
Circulation. 2000 Mar 21;101(11):1274-81
pubmed: 10725287
Circulation. 1997 Sep 2;96(5):1675-85
pubmed: 9315564
J Am Coll Cardiol. 2003 Sep 17;42(6):1108-14
pubmed: 13678939
Pacing Clin Electrophysiol. 2016 Sep;39(9):914-25
pubmed: 27418324
Circulation. 1995 Aug 15;92(4):835-41
pubmed: 7641364
Heart Rhythm. 2014 May;11(5):777-82
pubmed: 24561164
J Cardiovasc Electrophysiol. 2012 Dec;23(12):1277-85
pubmed: 23130890
Europace. 2010 Feb;12(2):160-72
pubmed: 19875395
J Am Soc Echocardiogr. 2016 May;29(5):461-9
pubmed: 26936152
J Am Coll Cardiol. 2004 Jun 16;43(12):2281-9
pubmed: 15193694
J Am Coll Cardiol. 2015 May 26;65(20):2159-69
pubmed: 25792361
JACC Case Rep. 2020 Oct 21;2(12):2004-2009
pubmed: 34317098
JAMA. 2004 Nov 24;292(20):2471-7
pubmed: 15562125
Circulation. 2002 Mar 5;105(9):1077-81
pubmed: 11877358
Front Physiol. 2017 Oct 11;8:792
pubmed: 29075201
Cardiovasc Res. 2004 Dec 1;64(3):387-94
pubmed: 15537491
Circulation. 2005 Aug 23;112(8):1232-40
pubmed: 16116073
Circulation. 1994 Feb;89(2):724-30
pubmed: 8313561
J Cardiovasc Electrophysiol. 1998 Jun;9(6):596-607
pubmed: 9654224
Circ Arrhythm Electrophysiol. 2008 Aug;1(3):184-92
pubmed: 19808412
Heart. 2001 Sep;86(3):265-70
pubmed: 11514476
Cardiovasc Res. 2005 Jan 1;65(1):40-51
pubmed: 15621032
Europace. 2015 Jan;17(1):56-63
pubmed: 25280910
Clin Cardiol. 2014 Jun;37(6):381-5
pubmed: 24700327
Cardiovasc Res. 2011 Mar 1;89(4):744-53
pubmed: 20962103
Circ Res. 1999 Jul 23;85(2):174-81
pubmed: 10417399
Eur Heart J. 2012 Nov;33(21):2709-17
pubmed: 22977225
Europace. 2009 Sep;11(9):1156-9
pubmed: 19633305
Circulation. 1997 Nov 18;96(10):3710-20
pubmed: 9396475
Am Heart J. 1959 Jul;58(1):59-70
pubmed: 13661062
Cathet Cardiovasc Diagn. 1982;8(2):173-83
pubmed: 7083327
Curr Treat Options Cardiovasc Med. 2018 Oct 26;20(12):98
pubmed: 30367267
Circ Cardiovasc Genet. 2017 Dec;10(6):
pubmed: 29237688
Heart Rhythm. 2019 Sep;16(9):1392-1398
pubmed: 30885736
Europace. 2017 Mar 1;19(3):356-363
pubmed: 26941337
J Thorac Cardiovasc Surg. 2013 Sep;146(3):593-8
pubmed: 22995722
Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1316-24
pubmed: 26283145
Circulation. 2005 Aug 30;112(9 Suppl):I7-13
pubmed: 16159868
Circulation. 1997 Oct 7;96(7):2455-61
pubmed: 9337224
Case Rep Cardiol. 2020 Jun 19;2020:9691584
pubmed: 32637178
Circulation. 2019 Nov 26;140(22):1779-1788
pubmed: 31630538
J Cardiovasc Electrophysiol. 1998 Dec;9(12):1378-93
pubmed: 9869538
Europace. 2012 Nov;14 Suppl 5:v106-v111
pubmed: 23104906
PLoS One. 2015 Mar 13;10(3):e0118746
pubmed: 25768978
Am J Cardiol. 1983 Jan 1;51(1):122-30
pubmed: 6849250
Heart Rhythm. 2016 Mar;13(3):636-41
pubmed: 26498260
Asian Cardiovasc Thorac Ann. 2008 Aug;16(4):292-7
pubmed: 18670021
Am J Epidemiol. 2018 Mar 1;187(3):417-426
pubmed: 28641376
Vet Clin North Am Small Anim Pract. 2004 Sep;34(5):1127-44, vi
pubmed: 15325473
Cardiovasc Res. 2002 May;54(2):230-46
pubmed: 12062329
Pacing Clin Electrophysiol. 2010 May;33(5):532-40
pubmed: 20132503
J Am Coll Cardiol. 1992 Aug;20(2):475-9
pubmed: 1634688
Heart Rhythm. 2007 Jul;4(7):938-49
pubmed: 17599682
Europace. 2016 Oct;18(10):1455-1490
pubmed: 27402624
Circ Arrhythm Electrophysiol. 2010 Jun;3(3):243-8
pubmed: 20339034
Circulation. 1995 Oct 1;92(7):1954-68
pubmed: 7671380
Can J Cardiol. 2018 Nov;34(11):1482-1491
pubmed: 30121148
J Am Vet Med Assoc. 1982 Feb 1;180(3):261-5
pubmed: 7056674

Auteurs

Adam Hartley (A)

National Heart and Lung Institute, Imperial College London, London, UK.

Joseph Shalhoub (J)

National Heart and Lung Institute, Imperial College London, London, UK.

Fu Siong Ng (FS)

National Heart and Lung Institute, Imperial College London, London, UK.

Andrew D Krahn (AD)

Division of Cardiology, University of British Columbia, 740 Hillside Ave, Vancouver, BC V8T 1Z4, Canada.

Zachary Laksman (Z)

Division of Cardiology, University of British Columbia, 740 Hillside Ave, Vancouver, BC V8T 1Z4, Canada.

Jason G Andrade (JG)

Division of Cardiology, University of British Columbia, 740 Hillside Ave, Vancouver, BC V8T 1Z4, Canada.

Marc W Deyell (MW)

Division of Cardiology, University of British Columbia, 740 Hillside Ave, Vancouver, BC V8T 1Z4, Canada.

Prapa Kanagaratnam (P)

National Heart and Lung Institute, Imperial College London, London, UK.

Markus B Sikkel (MB)

Division of Cardiology, University of British Columbia, 740 Hillside Ave, Vancouver, BC V8T 1Z4, Canada.
Division of Medical Sciences, University of Victoria, Victoria, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH